ISRG
Price
$542.54
Change
-$3.97 (-0.73%)
Updated
Oct 27, 11:32 AM (EDT)
Capitalization
193.74B
87 days until earnings call
Intraday Buy/Sell Signals
NTRA
Price
$193.08
Change
+$0.57 (+0.30%)
Updated
Oct 27, 03:01 PM (EDT)
Capitalization
26.42B
9 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ISRG vs NTRA

Header iconISRG vs NTRA Comparison
Open Charts ISRG vs NTRABanner chart's image
Intuitive Surgical
Price$542.54
Change-$3.97 (-0.73%)
Volume$1.13K
Capitalization193.74B
Natera
Price$193.08
Change+$0.57 (+0.30%)
Volume$200
Capitalization26.42B
ISRG vs NTRA Comparison Chart in %
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ISRG vs. NTRA commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Buy and NTRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (ISRG: $546.51 vs. NTRA: $192.51)
Brand notoriety: ISRG: Notable vs. NTRA: Not notable
ISRG represents the Pharmaceuticals: Other, while NTRA is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ISRG: 104% vs. NTRA: 101%
Market capitalization -- ISRG: $193.74B vs. NTRA: $26.42B
ISRG [@Pharmaceuticals: Other] is valued at $193.74B. NTRA’s [@Medical Specialties] market capitalization is $26.42B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.74B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12.01B. The average market capitalization across the [@Medical Specialties] industry is $12.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ISRG’s FA Score shows that 2 FA rating(s) are green whileNTRA’s FA Score has 0 green FA rating(s).

  • ISRG’s FA Score: 2 green, 3 red.
  • NTRA’s FA Score: 0 green, 5 red.
According to our system of comparison, ISRG is a better buy in the long-term than NTRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ISRG’s TA Score shows that 5 TA indicator(s) are bullish while NTRA’s TA Score has 5 bullish TA indicator(s).

  • ISRG’s TA Score: 5 bullish, 5 bearish.
  • NTRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NTRA is a better buy in the short-term than ISRG.

Price Growth

ISRG (@Pharmaceuticals: Other) experienced а +22.50% price change this week, while NTRA (@Medical Specialties) price change was +5.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.33%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was +12.59%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.97%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +39.84%.

Reported Earning Dates

ISRG is expected to report earnings on Jan 22, 2026.

NTRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.33% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+1.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ISRG($194B) has a higher market cap than NTRA($26.4B). NTRA YTD gains are higher at: 21.611 vs. ISRG (4.703). ISRG has higher annual earnings (EBITDA): 3.17B vs. NTRA (-211.86M). ISRG has more cash in the bank: 5.33B vs. NTRA (1.02B). ISRG has less debt than NTRA: ISRG (87M) vs NTRA (196M). ISRG has higher revenues than NTRA: ISRG (9.15B) vs NTRA (1.96B).
ISRGNTRAISRG / NTRA
Capitalization194B26.4B735%
EBITDA3.17B-211.86M-1,497%
Gain YTD4.70321.61122%
P/E Ratio72.29N/A-
Revenue9.15B1.96B466%
Total Cash5.33B1.02B524%
Total Debt87M196M44%
FUNDAMENTALS RATINGS
ISRG vs NTRA: Fundamental Ratings
ISRG
NTRA
OUTLOOK RATING
1..100
3638
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
2738
SMR RATING
1..100
5296
PRICE GROWTH RATING
1..100
1940
P/E GROWTH RATING
1..100
63100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (61) in the Biotechnology industry is in the same range as ISRG (91) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's Profit vs Risk Rating (27) in the Medical Specialties industry is in the same range as NTRA (38) in the Biotechnology industry. This means that ISRG’s stock grew similarly to NTRA’s over the last 12 months.

ISRG's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for NTRA (96) in the Biotechnology industry. This means that ISRG’s stock grew somewhat faster than NTRA’s over the last 12 months.

ISRG's Price Growth Rating (19) in the Medical Specialties industry is in the same range as NTRA (40) in the Biotechnology industry. This means that ISRG’s stock grew similarly to NTRA’s over the last 12 months.

ISRG's P/E Growth Rating (63) in the Medical Specialties industry is somewhat better than the same rating for NTRA (100) in the Biotechnology industry. This means that ISRG’s stock grew somewhat faster than NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ISRGNTRA
RSI
ODDS (%)
Bearish Trend 4 days ago
31%
Bearish Trend 4 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 4 days ago
82%
Momentum
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
56%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
58%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
43%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
62%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WAR26.170.42
+1.65%
U.S. Global Technology and Aerospace and Defense ETF
JQC5.100.02
+0.39%
Nuveen Credit Strategies Income Fund
MOTI38.910.10
+0.26%
VanEck Morningstar Intl Moat ETF
LQD112.720.19
+0.17%
iShares iBoxx $ Invmt Grade Corp Bd ETF
USL34.900.01
+0.01%
United States 12 Month Oil

ISRG and

Correlation & Price change

A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISRG
1D Price
Change %
ISRG100%
-0.87%
BSX - ISRG
73%
Closely correlated
-1.25%
SYK - ISRG
64%
Loosely correlated
-0.33%
NTRA - ISRG
54%
Loosely correlated
-1.28%
GKOS - ISRG
51%
Loosely correlated
-0.78%
MMSI - ISRG
51%
Loosely correlated
-0.71%
More